Clinical Efficacy of the Anti-Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Monoclonal Antibody Ipilimumab in Pretreated Metastatic Uveal Melanoma Patients

被引：0
|
作者：
Danielli, Riccardo [1 ]
Queirolow, Paola [2 ]
Testori, Alessandro [3 ]
Plummer, Ruth [6 ]
Sileni, Vanna Chiarion [4 ]
Altomonte, Maresa [1 ]
Calabro, Luana [1 ]
Di Giacomo, Anna Maria [1 ]
Ridolfi, Ruggero [5 ]
Maio, Michele [1 ]
机构：
[1] Univ Hosp ITT, Siena, Italy
[2] IST, Genoa, Italy
[3] IEO, Milan, Italy
[4] IOV, Padua, Italy
[5] IRST, Meldola, Italy
[6] Univ Newcastle, No Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England
来源：
JOURNAL OF IMMUNOTHERAPY | 2010年 / 33卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：894 / 894
页数：1
相关论文
共 50 条
  • [31] Cytotoxic T lymphocyte associated antigen-4 (CTLA-4) exon 1 A/G polymorphism in Iranian patients with multiple sclerosis
    Borhani-Haghighi, Afshin
    Ghahramani, Sulmaz
    Azarpira, Negar
    PourJafar, Mehrzad
    Nikseresht, Alireza
    MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (01) : 138 - 138
  • [32] Dose escalation phase 1 study of radiotherapy in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 monoclonal antibody ipilimumab in patients with metastatic melanoma
    Boutros, Celine
    Chaput-Gras, Nathalie
    Lanoy, Emilie
    Larive, Alicia
    Mateus, Christine
    Routier, Emilie
    Sun, Roger
    Tao, Yun Gan
    Massard, Christophe
    Bahleda, Rastilav
    Schwob, Dominique
    Ibrahim, Nathalie
    Khoury Abboud, Rita Maria
    Caramella, Caroline
    Lancia, Andrea
    Cassard, Lydie
    Roy, Severine
    Soria, J-C
    Robert, Caroline
    Deutsch, Eric
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [33] Cytotoxic T-lymphocyte antigen-4 (CTLA-4) exon 1 polymorphism affects lymphocyte profiles in bronchoalveolar lavage of patients with sarcoidosis
    Handa, T
    Nagai, S
    Ito, I
    Shigematsu, M
    Hamada, K
    Kitaichi, M
    Izumi, T
    Mishima, M
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2003, 20 (03) : 190 - 196
  • [34] Cytotoxic T-Lymphocyte Antigen-4 Blockade in Melanoma
    Buchbinder, Elizabeth I.
    McDermott, David F.
    CLINICAL THERAPEUTICS, 2015, 37 (04) : 755 - 763
  • [35] Anti-CTLA4 monoclonal antibody ipilimumab in the treatment of metastatic melanoma: Recent findings
    Lens, Marko
    Ferrucci, Pier F.
    Testori, Alessandro
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2008, 3 (02) : 105 - 113
  • [36] Current Understanding of Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Signaling in T-Cell Biology and Disease Therapy
    Kim, Gil-Ran
    Choi, Je-Min
    MOLECULES AND CELLS, 2022, 45 (08) : 513 - 521
  • [37] Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) in isolated vitiligo: a genotype-phenotype correlation
    Dwivedi, Mitesh
    Laddha, Naresh C.
    Imran, Mohomad
    Shah, Bela J.
    Begum, Rasheedunnisa
    PIGMENT CELL & MELANOMA RESEARCH, 2011, 24 (04) : 737 - 740
  • [38] A DNA vaccine against cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) prevents tumor growth
    Lan, Keng-Hsueh
    Liu, Yu-Chang
    Shih, Yi-Sheng
    Tsaid, Chang-Liang
    Yen, Sang-Hue
    Lan, Keng-Li
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 440 (02) : 222 - 228
  • [39] Cytotoxic T-lymphocyte antigen-4 (CTLA-4) polymorphisms and susceptibility to non Hodgkin's lymphoma.
    Monne, M
    Piras, G
    Palmas, AD
    Murineddu, M
    Arru, L
    Latte, G
    Uras, A
    Gabbas, A
    BLOOD, 2002, 100 (11) : 567A - 567A
  • [40] Role of the immunoglobulin constant region in the antitumor activity of antibodies to cytotoxic T-lymphocyte antigen-4 (CTLA-4)
    Korman, Alan J.
    Engelhardt, John
    Shahabi, Vafa
    Yordanova, Roumyana
    Henning, Karla
    Chen, Timothy
    Selby, Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345